Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radium-223 Maintenance in High-Volume mHSPC
NCT07717099Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of radium-223 dichloride in prostate cancer (PCa). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
radium-223 dichloride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07717099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717099.